Dennis Williams, PharmD Adaptimmune LLC

Dennis  Williams, PharmD

Dennis Williams, PharmD Adaptimmune LLC

Dennis Williams has served as Senior Vice President, Late Stage Development at Adaptimmune since December 2019. He is responsible for overseeing the late stage pipeline activities, including Phase 2/3 clinical trials through market application submission and approval.

Dr. Williams joined Adaptimmune in 2015 and served as Vice President, Global Regulatory Affairs. He has also led the ADP-A2M4 development program and previously led the NY-ESO development program prior to the transition of NY-ESO to GSK. 

Prior to joining Adaptimmune, Dr. Williams served as Director and Global Regulatory Lead at GSK Oncology, where he was instrumental in the development and approval of innovative products.

Dr. Williams has 20 years of experience in the pharmaceutical and biotech industries and started his career in the pharmaceutical industry in 2000 at Teva Pharmaceuticals. Dr. Williams holds a Doctorate in Pharmacy (PharmD) from the University of Florida and a Bachelor of Science degree in Pharmacy from Temple University.